by Healthcare Providers Acquire Financial Aid amid Ongoing COVID-19 Outbreak
Out-of-hospital care is anticipated to surge during the COVID-19 period. Stakeholders in the brucellosis vaccine market are increasing the availability of home healthcare providers, rehabilitation facilities, and long term care facilities. In-patient and community-based providers should review the current capacity for patients in both settings and plan for future pandemic-like situations.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111786
Companies in the brucellosis vaccine market are scrambling to maintain robust supply chains to improve patient outcomes and meet demands. They are looking for financial aid by governments and organizing employee wellness programs to prevent & mitigate burnout, review pay & benefits compared with the industry average. Interrupted clinical research and clinical trial activities are now being conducted utilizing telehealth options wherever possible.
Educational & Training Programs Help Control Brucellosis Disease in Colombia
Due to the presence of brucellosis in several susceptible production livestock systems scattered throughout Colombia, companies in the brucellosis vaccine market are making plans for its control, prevention, and eradication over the years. However, despite extensive efforts, brucellosis prevalence has fluctuated over the years without any trend of decreasing. Hence, companies are creating awareness about high impact educational and training programs required to address the disease in a comprehensive manner.
Companies in the Colombia brucellosis vaccine market are targeting vulnerable groups such as traditional smallholders, veterinary authorities, and communities in low productivity regions for their educational and training programs.
India Holds Lucrative Incremental Opportunities for Brucellosis Vaccine Manufacturers
The global brucellosis vaccine market is projected to grow at a CAGR of 4% during the forecast period. Companies are tapping value-grab opportunities in India, since the Animal Husbandry Department in Yadgir has planned to vaccinate cattle and buffalo calves to prevent brucellosis disease under the National Animal Disease Control Programme (NADCP). Several thousand cattle and buffalo calves are being vaccinated under this flagship scheme launched by the Union Government of India.
Since brucellosis is a serious infectious disease that can cause abortion or loss of reproductivity, companies in the India brucellosis vaccine market are increasing output capacities to improve clinical outcomes in cattle and buffalo. Mass inoculation of cattle and buffalo is being conducted on priority in India to prevent the spread of the disease from animals to human beings.
Guinea Pig Model Holds Promising Potentials to Develop Well-tolerated Brucellosis Vaccines
Apart from developing vaccines for animals, companies in the brucellosis vaccine market are diversifying their research capabilities to innovate in vaccines for humans.
In order to develop new vaccine candidates, there is a need to comply with the set industry standards before selecting the viral vectors and the method for preparing & using the vaccine. Companies are increasing their R&D capabilities using the study of protection of the vaccine with the help of guinea pigs, including various options for administering, dose, and frequency. They are innovating in brucellosis vaccines that can be well-tolerated in humans by upgrading the production technology and testing in healthcare practice.
Analysts’ Viewpoint
Stakeholders in the brucellosis vaccine market are reviewing financial assistance programs associated with COVID-19 appropriations for eligibility. Restricted budgets for brucellosis control in Colombia is affecting the overall animal welfare in the region. Hence, stakeholders in Colombia should increase efforts for important financial investments based on sustained cooperation between governmental institutions, industry, and farmers for developing affordable and effective strategies to control the disease. On-farm detection involves the use of a screening test, followed by a confirmatory test. Testing is mandatory for international trade, animal movements in Colombia, and for clinically suspected animals. This involves the Rose Bengal Plate Test (RBPT) or Indirect ELISA as a screening test.
Brucellosis Vaccine Market: Overview
Brucellosis, often referred as Bang’s disease, contagious abortion, or infectious abortion, affects cattle, buffaloes, sheep, goats, camels, pigs, dogs, horses, deer, yaks, and feral animals as well as humans. The disease causes considerable economic loss and is a serious public health concern.
Various types of brucellosis species are found in different kinds of animals including Brucella abortus (from cattle), Brucella abortus (from cattle), Brucella abortus (from cattle), Brucella abortus (from cattle), and others
Rise in prevalence of brucellosis and increase in awareness among people are projected to drive the global brucellosis vaccine market during the forecast period
Brucellosis Vaccine Market: Key Drivers
Most human zoonotic infections are transmitted by livestock. Zoonotic diseases account for 61% of the total animal diseases. For instance, brucellosis and foot-and-mouth are the major diseases in animals. Increase in number of cases of brucellosis propels the global brucellosis vaccine market. Rise in the number of brucellosis cases in India, Brazil, Mexico, and other countries is likely to drive the global market. The global burden of human brucellosis is quite high. Over 500,000 infections are caused by animals across the world every year.
Awareness about animal diseases, their symptoms, and medications is most important for livestock owners. Several animal health awareness programs have been conducted to increase awareness among people. In India, the National Animal Disease Control Programme (NADCP) is a flagship scheme launched by Honorable Prime Minister in September 2019 for control of foot & mouth disease and brucellosis by vaccinating 100% cattle, buffalo, sheep, goat, and pig population against FMD and 100% bovine female calves of four to eight months of age against brucellosis.
Brucellosis Vaccine Market: Segmentation
In terms of type, the global brucellosis vaccine market has been classified into RB51 vaccine, S19 vaccine, and others
Based on vaccine type, the global brucellosis vaccine market has been categorized into DNA vaccine, subunit vaccine, vector vaccine, and recombinant vaccine
In terms of application, the global brucellosis vaccine market has been segregated into cattle, sheep & goat, and others
Based on distribution channel, the global brucellosis vaccine market has been divided into veterinary hospitals & clinics, retail channels, and others
Each of the segments has been analyzed in detail for brucellosis vaccine trends, recent trends & developments, drivers, restraints, opportunities, and useful insights. The brucellosis vaccine market report provides current and future revenue (US$ Mn) for each of these segments for the period from 2017 to 2031, considering 2020 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2021 to 2031, along with market size estimations.
Brucellosis Vaccine Market: Regional Overview
In terms of region, the global brucellosis vaccine market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The regions have been divided into major countries and sub-regions.
Asia Pacific accounted for the largest share of the global brucellosis vaccine market in 2020 and the trend is projected to continue during the forecast period. Growth of the brucellosis vaccine market in the region can be ascribed to presence of major players and high cattle population.
Asia Pacific is anticipated to gain market share during the forecast period. Product launches, acquisitions, distribution agreements, alliances, and geographical expansion by local players, especially in China and India, are expected to propel the brucellosis vaccine market in the region.
The current and future market sizes in terms of value (US$ Mn) of these regional markets and major countries have been provided in the report for the period from 2017 to 2031 along with CAGRs for the period from 2021 to 2031
The study also offers a list of recommendations, highlights, and useful insights of the market, which are likely to help new companies willing to enter the market and existing companies to increase market share and in the decision-making process
Major Players
The report concludes with the company profiles section, which includes key information about the major players in the global brucellosis vaccine market
Leading players analyzed in the report are
- Merck Animal Health
- Ceva Sante Animale
- CZ Vaccines
- Colorado Serum Company
- Indian Immunologicals Ltd.
- Hester Biosciences Limited
- Veterinary Technologies Corporation
- Fivet Animal Health
- Jordan Bio-industries Center
- Laboratories Tornel
Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments
Key Questions Answered in Brucellosis Vaccine Market Report
- What is the sales/revenue generated by brucellosis vaccines across all regions during the forecast period?
- What are the opportunities in the global brucellosis vaccine market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which type is expected to generate the highest revenue globally in 2031? Which segment is projected to expand at the highest CAGR during the forecast period?
- What is the market position of different companies operating in the global market?
Brucellosis Vaccine Market – Segmentation
Type
- RB51 Vaccine
- S19 Vaccine
- Others
Vaccine Type
- DNA Vaccine
- Subunit Vaccine
- Vector Vaccine
- Recombinant Vaccine
Application
- Cattle
- Sheep & Goat
- Others
Distribution Channel
- Veterinary Hospitals & Clinics
- Retail Channels
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111786/2900
